Sonic Hedgehog pathway inhibitors: from clinical trials to clinical practice.
作者信息
Yan B Y, Hibler B P, Menge T, Dunn L, Ho A L, Rossi A M
机构信息
Memorial Sloan Kettering Cancer Center, Dermatology Service 16 E. 60th Street, 4th Floor Dermatology, New York, NY, 10022, U.S.A.
出版信息
Br J Dermatol. 2019 May;180(5):1260-1261. doi: 10.1111/bjd.17692. Epub 2019 Mar 7.
Abstract
摘要
相似文献
1
Sonic Hedgehog pathway inhibitors: from clinical trials to clinical practice.音猬因子信号通路抑制剂：从临床试验到临床实践
Br J Dermatol. 2019 May;180(5):1260-1261. doi: 10.1111/bjd.17692. Epub 2019 Mar 7.
2
Harnessing hedgehog for the treatment of basal cell carcinoma.利用刺猬信号通路治疗基底细胞癌。
JAMA Dermatol. 2013 May;149(5):607-8. doi: 10.1001/jamadermatol.2013.448.
3
Small Molecule Inhibitors of the Hedgehog Pathway in the Treatment of Basal Cell Carcinoma of the Skin.小分子抑制剂在治疗皮肤基底细胞癌中的 Hedgehog 通路作用。
Am J Clin Dermatol. 2018 Apr;19(2):195-207. doi: 10.1007/s40257-017-0319-4.
4
Hedgehog Pathway Inhibition.刺猬通路抑制。
Cell. 2016 Feb 25;164(5):831. doi: 10.1016/j.cell.2016.02.021.
5
High-Risk Recurrence Basal Cell Carcinoma: Focus on Hedgehog Pathway Inhibitors and Review of the Literature.高危复发性基底细胞癌：聚焦 Hedgehog 通路抑制剂及文献复习。
Chemotherapy. 2020;65(1-2):2-10. doi: 10.1159/000509156. Epub 2020 Aug 10.
6
Vismodegib (Erivedge) for basal cell carcinoma.维莫德吉（Erivedge）用于治疗基底细胞癌。
Med Lett Drugs Ther. 2012 Jul 9;54(1394):53-4.
7
Hedgehog hopes lifted by approval... and stung by failure.刺猬因获批而满怀希望……又因失败而备受刺痛。
Nat Biotechnol. 2012 Mar 7;30(3):203. doi: 10.1038/nbt0312-203.
8
Sonidegib for the treatment of advanced basal cell carcinoma: a comprehensive review of sonidegib and the BOLT trial with 12-month update.索尼替尼治疗晚期基底细胞癌：全面综述索尼替尼和 BOLT 试验及其 12 个月更新。
Future Oncol. 2016 Sep;12(18):2095-105. doi: 10.2217/fon-2016-0118. Epub 2016 May 18.
9
Vismodegib: a guide to its use in locally advanced or metastatic basal cell carcinoma.维莫德吉：局部晚期或转移性基底细胞癌治疗中的应用指南。
Am J Clin Dermatol. 2013 Feb;14(1):61-4. doi: 10.1007/s40257-012-0004-6.
10
Oral hedgehog-pathway inhibitors for basal-cell carcinoma.用于基底细胞癌的口服刺猬信号通路抑制剂
N Engl J Med. 2012 Jun 7;366(23):2225-6. doi: 10.1056/NEJMe1202170.
引用本文的文献
1
Trichoblastic carcinoma: a systematic review of an aggressive follicular neoplasm with an emphasis on Mohs micrographic surgery in management.毛囊母质癌：一种侵袭性毛囊肿瘤的系统综述，重点关注莫氏显微外科手术在其治疗中的应用。
Arch Dermatol Res. 2025 May 25;317(1):783. doi: 10.1007/s00403-025-04275-y.
本文引用的文献
1
Vismodegib Use in Clinical Practice: Analysis of a United States Medical Claims Database.维莫德吉在临床实践中的应用：对美国医疗索赔数据库的分析
J Drugs Dermatol. 2018 Feb 1;17(2):143-148.
2
Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma: final update of the pivotal ERIVANCE BCC study.维莫德吉治疗晚期基底细胞癌患者的长期安全性和有效性：关键ERIVANCE BCC研究的最终更新
BMC Cancer. 2017 May 16;17(1):332. doi: 10.1186/s12885-017-3286-5.
3
Hedgehog Pathway Inhibitor Therapy for Locally Advanced and Metastatic Basal Cell Carcinoma: A Systematic Review and Pooled Analysis of Interventional Studies.Hedgehog 通路抑制剂治疗局部晚期和转移性基底细胞癌：干预性研究的系统评价和汇总分析。
JAMA Dermatol. 2016 Jul 1;152(7):816-24. doi: 10.1001/jamadermatol.2016.0780.
4
A phase II, multicenter, open-label, 3-cohort trial evaluating the efficacy and safety of vismodegib in operable basal cell carcinoma.一项评估维莫德吉在可手术基底细胞癌中的疗效和安全性的 II 期、多中心、开放标签、3 队列试验。
J Am Acad Dermatol. 2015 Jul;73(1):99-105.e1. doi: 10.1016/j.jaad.2015.03.013. Epub 2015 Apr 24.
Zotero 插件